RNANIMAL
DEAD

Serial Number

87425955

Owner

CUREVAC SE

Attorney

Jennifer Fraser

Filing Date

Apr 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

RNANIMAL Trademark

Serial Number: 87425955 • Registration: 5593015

RNANIMAL is a trademark filed by CUREVAC SE on April 26, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CUREVAC SE (14 trademarks)

FRIEDRICH-MIESCHER-STR. 15
TÜBINGEN 72076 , DE

Entity Type: 94

CUREVAC AG (20 trademarks)

PAUL-EHRLICH-STRASSE 15
TUEBINGEN 72076 , DE

Entity Type: 25

Trademark Details

Filing Date

April 26, 2017

Registration Date

October 30, 2018

Published for Opposition

August 14, 2018

Cancellation Date

May 16, 2025

Goods & Services

Chemical preparations for pharmaceutical or medical or veterinary medical purposes or pharmaceutical and veterinary medical preparations, in particular for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases or of heritable genetic diseases or for therapies replacing proteins or enzymes; immunostimulatory compositions, in particular for veterinary medical purposes; vaccines, in particular for veterinary medical purposes; adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases or for therapies replacing proteins or enzymes; gene therapy products for human or veterinary use; gene therapy products, namely, nucleic acid macromolecules for in vivo expression; food supplements for veterinary medical use

Chemical reagents and biomolecules, in particular biological macromolecules for industry and science, reagents for research purposes

Medical and veterinary services, in particular for therapeutical and prophylactic treatment of tumor diseases, infectious diseases, autoimmune diseases or allergies, of hereditary disorders, of allergies, and for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular disorders and for the treatment of endocrinological disorders

Scientific and technological services, namely, technical consulting and scientific research services, in particular for identifying and characterizing biological macromolecules

Filing History

CANCELLED SEC. 8 (6-YR)
May 16, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 30, 2023 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 8, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Sep 26, 2018 CHPB
ASSIGNED TO PETITION STAFF
Sep 25, 2018 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 29, 2018 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 14, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 14, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 29, 2018 CRFA
ASSIGNED TO LIE
Jun 28, 2018 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 13, 2018 ERSI
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 12, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 12, 2018 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 5, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 5, 2018 GNSL
SUSPENSION LETTER WRITTEN
Feb 5, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 1, 2017 GPRN
PRIORITY ACTION E-MAILED
Aug 1, 2017 GPRA
PRIORITY ACTION WRITTEN
Aug 1, 2017 CPRA
ASSIGNED TO EXAMINER
Jul 24, 2017 DOCK
NOTICE OF PSEUDO MARK E-MAILED
May 4, 2017 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2017 NWOS
NEW APPLICATION ENTERED
Apr 29, 2017 NWAP